LB Pharmaceuticals (LBRX) Q2 2026 Earnings

12MayConfirmed
Q3 2025
Q4 2025
Q2 2026
-1.44
-1.15
-0.86
-0.57

Details

Expected EPS
-0.745
Actual EPS
-0.67
Surprise EPS
0.07
Surprise Percent
+10.07%

Description

LB Pharmaceuticals (LBRX) has reported earnings of -0.67 per share for Q2 2026.

0 Comments

Share your thoughts